No shortage on file

APO-EMTRICITABINE-TENOFOVIR

APOTEX INC

Quick answers

Is there a shortage of APO-EMTRICITABINE-TENOFOVIR in Canada?

No. There is no current shortage of APO-EMTRICITABINE-TENOFOVIR 300MG 200MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

Checked by MedShort2026-11-13

DIN

02452006

Strength

300MG 200MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-11-12

Resolved

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244